Effect of Gonadal Hormones on Colonic Contractile Activity in Albino Rats
American Journal of Internal Medicine
Volume 5, Issue 2, March 2017, Pages: 26-36
Received: Mar. 3, 2017; Accepted: Mar. 27, 2017; Published: Apr. 17, 2017
Views 1501      Downloads 42
Author
Mohamad Yosof Rezk, Physiology Unit, Basic Medical Sciences Department, College of Medicine and Medical Sciences in Unaizah, Qassim University, Unaizah, KSA
Article Tools
Follow on us
Abstract
Sex differences were reported in Irritable Bowel Syndrome. We aimed to demonstrate the effect of gonadal hormones on colonic contractile activity. In this study, we performed in vitro measurements of colonic contractile activity in longitudinal smooth muscle strips of female and male Albino rats. After administration of a gonadal hormone (estrogen (EST), progesterone (PROG) and testosterone (TEST)) or ethanol (ETH) solution as control, stimulation with acetylcholine (ACh) or inhibition with norepinephrine (NE) was performed. We found that increasing doses of EST resulted in a stepwise inhibition of SCCA in both sexes and inhibited the ACh effect in females. Similarly, high dose PROG inhibited SCCA in females. TEST inhibited SCCA in males but not Ach induced contractions. TEST reduced the inhibitory effect of NE in female rats. In conclusion, exposure of colonic smooth muscle strips to gonadal hormones led to sex-dependent changes in SCCA and modified the response of smooth muscle strips to both pro-contractile and anti-contractile neurotransmitters.
Keywords
Colonic Smooth Muscle, Estrogen, Bowel Disorders, Gonadal Hormones, Irritable Bowel Syndrome, Motility
To cite this article
Mohamad Yosof Rezk, Effect of Gonadal Hormones on Colonic Contractile Activity in Albino Rats, American Journal of Internal Medicine. Vol. 5, No. 2, 2017, pp. 26-36. doi: 10.11648/j.ajim.20170502.13
Copyright
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123 (6): 2108-31. Lacy BE, Mearin F, Chang L et al. Bowel disorders. Gastroenterology 2016; 150 (6): 1393-1407.
[2]
Wilson S, Roberts L, Roalfe A, Bridge P, Singh S. Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract 2004; 54 (504): 495-502.
[3]
Brandt LJ, Chey WD, Foxx-Orenstein AE, et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009; 104 Suppl 1: S1-35.
[4]
Meleine M, Matricon J. Gender-related differences in irritable bowel syndrome: Potential mechanisms of sex hormones. World J Gastroenterol 2014; 20 (22): 6725-43.
[5]
Whitehead WE, Holtkotter B, Enck P, et al. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology 1990; 98 (5 Pt 1): 1187-92. Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA 2015; 313 (9): 949-58.
[6]
Serra J, Azpiroz F, Malagelada JR. Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut 2001; 48 (1): 14-9.
[7]
Bouin M, Plourde V, Boivin M, et al. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002; 122 (7): 1771- 7.
[8]
Liebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007; 132 (3): 913-20.
[9]
Chadwick VS, Chen W, Shu D, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002; 122 (7): 1778-83.
[10]
Snape WJ, Jr., Carlson GM, Cohen S. Colonic myoelectric activity in the irritable bowel syndrome. Gastroenterology 1976; 70 (3): 326-30.
[11]
Kellow JE, Gill RC, Wingate DL. Prolonged ambulant recordings of small bowel motility demonstrate abnormalities in the irritable bowel syndrome. Gastroenterology 1990; 98 (5 Pt 1): 1208-18.
[12]
Chang L, Heitkemper MM. Gender differences in irritable bowel syndrome. Gastroenterology 2002; 123 (5): 1686-1701.
[13]
28. Karantanos T, Markoutsaki T, Gazouli M, Anagnou NP, Karamanolis DG. Current insights in to the pathophysiology of Irritable Bowel Syndrome. Gut Pathog 2010; 2 (1): 3.
[14]
Cui N, Wu BP, Wu SZ. [Association of peripheral blood estradiol, progesterone and testosterone levels with irritable bowel syndrome]. Nan Fang Yi Ke Da Xue Xue Bao 2006; 26 (3): 367-8.
[15]
Heitkemper MM, Chang L. Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome? Gend Med 2009; 6 Suppl 2: 152-67.
[16]
Ryan JP, Bhojwani A. Colonic transit in rats: effect of ovariectomy, sex steroid hormones, and pregnancy. Am J Physiol 1986; 251 (1 Pt 1): G46- 50.
[17]
Gonenne J, Esfandyari T, Camilleri M, et al. Effect of female sexhormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women. Neurogastroenterol Motil 2006; 18 (10): 911-8.
[18]
Hogan AM, Kennelly R, Collins D, Baird AW, Winter DC. Oestrogen inhibits human colonic motility by a non-genomic cell membrane receptor-dependent mechanism. Br J Surg 2009; 96 (7): 817-22.
[19]
Domali, E.; asprodini, E.; Molyvads, P. A. and Messinis, I. E.: In Vitro effects of Endothelin-1 on the contractility of myometrium obtained from pre- and postmenopausal women. J Endocrinol, 2001; 168 (1): 153-162.
[20]
Heitkemper MM, Bond EF. Gastric motility in rats with varying ovarian hormone status. West J Nurs Res 1995; 17 (1): 9-19.
[21]
Doolan CM, Harvey BJ. A Galphas protein-coupled membrane receptor, distinct from the classical oestrogen receptor, transduces rapid effects of oestradiol on [Ca2+]i in female rat distal colon. Mol Cell Endocrinol 2003; 199 (1-2): 87-103.
[22]
Sylvia VL, Walton J, Lopez D, Dean DD, Boyan BD, Schwartz Z. 17 betaestradiol- BSA conjugates and 17 beta-estradiol regulate growth plate chondrocytes by common membrane associated mechanisms involving PKC dependent and independent signal transduction. J Cell Biochem 2001; 81 (3): 413-29.
[23]
Falkenstein E, Wehling M. Nongenomically initiated steroid actions. Eur J Clin Invest 2000; 30 Suppl 3: 51-4.
[24]
Oh ST, Yedidag E, Bielefeldt K. Differential effects of progesterone and its analogues on the contractility of the murine jejunum in vitro. J Surg Res 1998; 75 (1): 1-5.
[25]
Braverman DZ, Johnson ML, Kern F, Jr. Effects of pregnancy and contraceptive steroids on gallbladder function. N Engl J Med 1980; 302 (7): 362-4.
[26]
Xiao ZL, Pricolo V, Biancani P, Behar J. Role of progesterone signaling in the regulation of G-protein levels in female chronic constipation. Gastroenterology 2005; 128 (3): 667-75.
[27]
Bielefeldt K, Waite L, Abboud FM, Conklin JL. Nongenomic effects of progesterone on human intestinal smooth muscle cells. Am J Physiol 1996; 271 (2 Pt 1): G370-6.
[28]
Xiao ZL, Cao W, Biancani P, Behar J. Nongenomic effects of progesterone on the contraction of muscle cells from the guinea pig colon. Am J Physiol Gastrointest Liver Physiol 2006; 290 (5): G1008-15.
[29]
Tang YR, Yang WW, Wang Y, Gong YY, Jiang LQ, Lin L. Estrogen regulates the expression of small-conductance Ca2+-activated K+ channels in colonic smooth muscle cells. Digestion 2015; 91: 187-96.
[30]
Cirillo DJ, Wallace RB, Rodabough RJ, et al. Effect of estrogen therapy on gallbladder disease. Jama 2005; 293 (3): 330-9.
[31]
Everson GT. Gastrointestinal motility in pregnancy. Gastroenterol Clin North Am 1992; 21 (4): 751-76.
[32]
Valeri A, Brain KL, Young JS, Sgaragli G, Pessina F. Effects of 17betaoestradiol on rat detrusor smooth muscle contractility. Exp Physiol 2009; 94 (7): 834-46.
[33]
Dambros M, van Koeveringe GA, Bast A, van Kerrebroeck PE. Relaxant effects of estradiol through non-genomic pathways in male and female pig bladder smooth muscle. Pharmacology 2004; 72 (2): 121-7.
[34]
Bruce LA, Beshudi FM. Increased gastrointestinal motility in vitro following chronic estrogen treatment in male rats. Proc Soc Exp Biol Med 1981; 166 (3): 355-9.
[35]
Li CP, Ling C, Biancani P, Behar J. Effect of progesterone on colonic motility and fecal output in mice with diarrhea. Neurogastroenterol Motil 2012; 24: 392-e174.
[36]
Wang F, Zheng TZ, Li W, Qu SY, He DY. Action of progesterone on contractile activity of isolated gastric strips in rats. World J Gastroenterol 2003; 9 (4): 775-8.
[37]
Shah S, Nathan L, Singh R, Fu YS, Chaudhuri G. E2 and not P4 increases NO release from NANC nerves of the gastrointestinal tract: implications in pregnancy. Am J Physiol Regul Integr Comp Physiol 2001; 280 (5): R1546-54.
[38]
Scott AP, Sheldrick EL, Flint AP. Measurement of 17 alpha, 20 betadihydroxy- 4-pregnen-3-one in plasma of trout (Salmo gairdneri Richardson): seasonal changes and response to salmon pituitary extract. Gen Comp Endocrinol 1982; 46 (4): 444-51.
[39]
Elhadd TA, Neary R, Abdu TA, et al. Influence of the hormonal changes during the normal menstrual cycle in healthy young women on soluble adhesion molecules, plasma homocysteine, free radical markers and lipoprotein fractions. Int Angiol 2003; 22 (3): 222-8.
[40]
Zhang L. Muscarinic receptors in developing rat colon. Eur J Pharmacol 1996; 304 (1-3): 211-9.
[41]
Zhang LB, Buxton IL. Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways. Mol Pharmacol 1991; 40 (6): 952-9.
[42]
Yamaguchi K, Honda H, Tamura K, Kogo H. Possible mechanisms for the suppressing action of 17beta-estradiol on beta-adrenoceptormediated vasorelaxation in rat aorta. Eur J Pharmacol 2001; 427 (1): 61-7.
[43]
Riemer RK, Goldfien A, Roberts JM. Rabbit myometrial adrenergic sensitivity is increased by estrogen but is independent of changes in alpha adrenoceptor concentration. J Pharmacol Exp Ther 1987; 240 (1): 44-50.
[44]
Gonzalez-Montelongo MC, Marin R, Gomez T, Marrero-Alonso J, Diaz M. Androgens induce nongenomic stimulation of colonic contractile activity through induction of calcium sensitization and phosphorylation of LC20 and CPI-17. Mol Endocrinol 2010; 24 (5): 1007-23.
[45]
Simoncini T, Genazzani AR. Non-genomic actions of sex steroid hormones. Eur J Endocrinol 2003; 148 (3): 281-92.
[46]
Boonyaratanakornkit V, Edwards DP. Receptor mechanisms mediating non-genomic actions of sex steroids. Semin Reprod Med 2007; 25 (3): 139-53.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186